7 unknown. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 7 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Vascular Dementia: new trials by email Literature Review of Vascular Dementia trials Research Report on Vascular Dementia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia Tian Ma Bian Chun Zhi Gan Tablets, Placebo - Vascular Dementia, Cognitive Impairment | Phase 2 | Unknown | Dongzhimen Hospital, Beijing | 360 | 2022-05-25 | 2022-11-22 |
| A Noval Tau Tracer in Young Onset Dementia 18F-PM-PBB3 - Alzheimer's Disease, Vascular Dementia | Phase 1 / Phase 2 | Unknown | Chang Gung Memorial Hospital | 100 | 2020-02-20 | 2020-01-30 |
| Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment Remote ischemic conditioning - Vascular Dementia, Cerebral Small Vessel Diseases | Phase 2 | Unknown | University of Calgary | 24 | 2019-09-26 | 2022-06-09 |
| n-3 PUFA for Vascular Cognitive Aging Omega 3 PUFA, Placebo - Age Related Cognitive Decline, Alzheimer's Disease | Phase 2 | Unknown | Oregon Health and Science University | 102 | 2014-05-01 | 2020-09-04 |
| Symptomatic Treatment of Vascular Cognitive Impairment Galantamine, Methylphenidate, Placebo - Mild Cognitive Impairment (Vascular), Mild Cognitive Disorder (Vascular) | Phase 2 / Phase 3 | Unknown | Amsterdam UMC, location VUmc | 30 | 2014-02-01 | 2016-05-02 |
| The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule high dose group of SaiLuoTong capsule, low dose group of SaiLuoTong, the control group - Vascular Dementia | Phase 2 | Unknown | Shineway Pharmaceutical Co.,Ltd | 372 | 2011-12-01 | 2014-05-08 |
| Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity Zydena (Udenafil), Placebo - Vascular Dementia, Subcortical Vascular Dementia | Phase 2 | Unknown | Samsung Medical Center | 80 | 2011-11-01 | 2011-11-08 |
Dementia, Vascular (7) · Cognitive Dysfunction (3) · Alzheimer Disease (2) · Cerebral Small Vessel Diseases (1) · Dementia (1) · Memory Disorders (1) · Neurocognitive Disorders (1) · Stroke (1)
Arterial Occlusive Diseases (7) · Arteriosclerosis (7) · Brain Diseases (7) · Cardiovascular Diseases (7) · Central Nervous System Diseases (7) · Cerebrovascular Disorders (7) · Intracranial Arterial Diseases (7) · Intracranial Arteriosclerosis (7) · Leukoencephalopathies (7) · Mental Disorders (7) · Nervous System Diseases (7) · Vascular Diseases (7) · Dementia (6) · Neurocognitive Disorders (6) · Cognition Disorders (3)
Fish Oils (1) · Galantamine (1) · Methylphenidate (1) · Soybean Oil (1) · udenafil (1)
Amsterdam UMC, location VUmc (1) · Chang Gung Memorial Hospital (1) · Dongzhimen Hospital, Beijing (1) · Oregon Health and Science University (1) · Samsung Medical Center (1) · Shineway Pharmaceutical Co.,Ltd (1) · University of Calgary (1)
China (2) · Canada (1) · Netherlands (1) · South Korea (1) · United States (1)
Baojun Wang, Doctor (1) · Benyan Luo, Doctor (1) · Changshan Ai, Master (1) · Desheng Zhou, Doctor (1) · Dongdong Yang, Doctor (1) · Duk L. Na, MD. PhD. (1) · Eric Smith, MD (1) · Gene Bowman, ND, MPH (1) · Jiang Wu, Doctor (1) · Jianming Lv (1) · Jianping Jia, professor (1) · Jimei Li, Bachelor (1) · Jinzhou Tian (1) · Lynne Shinto, ND, MPH (1) · Niels D Prins, MD, PhD (1)
PMID 29559423, PMID 30934894, PMID 31910895, PMID 33055122, PMID 39088212
R01AG043398 (1)